| Serial Number | 98729743 |
| Word Mark | EXPANDING ACCESS TO QUALITY, AFFORDABLE MEDICATION |
| Filing Date | Tuesday, September 3, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Thursday, June 19, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Supply chain management services in the field of pharmaceuticals |
| Goods and Services | Regulatory compliance consulting in the field of pharmaceuticals |
| Goods and Services | Pharmaceutical drug development services and contract pharmaceutical drug development services; Research and development services of pharmaceutical products and preparations; Research and development services of pharmaceutical products and preparations for others; Conducting pharmaceutical research, pharmaceutical drug formulation development, scientific research in the nature of conducting clinical trials for others, commercial production in the nature of pharmaceutical products development, packaging design, and quality assurance for others in the pharmaceutical industry in the field of pharmaceuticals; Conducting post-marketing product support for others in the pharmaceutical industry in the field of pharmaceuticals, namely, post-market surveillance, clinical trials, and studies to further assess the safety, efficacy, or optimal use of approved products; Laboratory research services and contract research services, namely, analytical and microbiological testing for others in the pharmaceutical industry; Research laboratory analysis for others in the field of pharmaceuticals; Scientific laboratory services in the fields of pharmacology, microbiology, toxicology, and biotechnology; Testing and analysis of pharmaceuticals per industry standards and for compliance with the requirements of the United States Pharmacopeia regulatory requirements; Quality control testing for others in the pharmaceutical industry; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of pharmacology, microbiology, toxicology, and biotechnology; Testing of pharmaceutical raw materials to determine conformity with established regulatory standards |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 19, 2025 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 3, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 19, 2025 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Empower Clinic Services, L.L.C. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Houston, TX 77064 |
| Event Date | Event Description |
| Tuesday, September 3, 2024 | NEW APPLICATION ENTERED |
| Thursday, March 13, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 14, 2025 | ASSIGNED TO EXAMINER |
| Monday, April 7, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, April 7, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, April 7, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 19, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 19, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 19, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |